The FDA investigation into AC and GLP-1 RA drugs reported: The median age for people who developed AC was 55 years old Of the people who developed AC, 53% were female After starting the drug, 47% of patients developed AC within 90 days Cholelithiasis, or gallstones, was also added to the approval label
You wont be put on a restrictive crash diet, but we do provide nutritional guidance
Less flexibility on dose adjustments
The science behind it is compelling: research shows that NAD+ levels can drop by up to 50 percent between ages 40 and 60 ( Trammell et al., Cell Metabolism, 2016 ), leading to slower cellular repair, mitochondrial fatigue, and visible skin aging
The path from animal models to approved human therapy is long, and many promising programs fail along the way